EPIC-波茨坦前瞻性队列研究中血浆脂质组n-6多不饱和脂肪酸与2型糖尿病风险
在EPIC-波茨坦前瞻性队列的巢式病例队列研究中(子队列1084人,2型糖尿病536例,中位随访6.5年),检测12类脂质中18:2、20:3和20:4浓度。18:2较高与2型糖尿病风险负相关,20:3较高与风险正相关,20:4与风险无关,D5D活性与风险降低相关。
要点
- 18:2在单酰甘油中每升高1个标准差,2型糖尿病风险HR为0.59(95%CI 0.38-0.92)。
- 20:3在磷脂酰胆碱中每升高1个标准差,2型糖尿病风险HR为1.63(95%CI 1.23-2.14)。
- 20:4浓度与2型糖尿病风险无关联,磷脂和胆固醇酯中D5D活性与风险降低相关。
核心结论
- 血浆n-6多不饱和脂肪酸与2型糖尿病风险的关联因脂肪酸种类和脂质类别而异。
研究设计与样本
- 欧洲癌症与营养前瞻性调查(EPIC)-波茨坦队列的巢式病例队列研究,子队列1084人,2型糖尿病536例,中位随访6.5年。
主要发现
- 18:2在溶血磷脂酰胆碱中每升高1个标准差,2型糖尿病风险HR为0.53(95%CI 0.23-1.26),在单酰甘油中HR为0.59(95%CI 0.38-0.92)。
- 20:3在磷脂酰胆碱中每升高1个标准差,2型糖尿病风险HR为1.63(95%CI 1.23-2.14),在磷脂酰乙醇胺中HR为1.87(95%CI 1.32-2.65),在磷脂酰肌醇中HR为1.40(95%CI 1.05-1.87)。
- 20:3在游离脂肪酸中每升高1个标准差,2型糖尿病风险HR为1.44(95%CI 1.10-1.90),在胆固醇酯中HR为1.47(95%CI 1.09-1.98),多重检验校正后仍显著。
- 20:4浓度与2型糖尿病风险无关联。
- 磷脂和胆固醇酯中估计的D5D活性与2型糖尿病风险降低相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Evidence on plasma n-6 polyunsaturated fatty acids (PUFAs) and type 2 diabetes risk is inconsistent. We examined the associations of lipid class-specific PUFA concentrations with type 2 diabetes risk. RESEARCH DESIGN AND METHODS: In the prospective European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam cohort (nested case-cohort study: subcohort 1,084 participants, 536 participants with type 2 diabetes, median follow-up 6.5 years), we measured plasma 18:2, 20:3, and 20:4 concentrations in 12 lipid (sub)classes, likely reflecting the plasma concentrations of linoleic acid (18:2n-6), dihomo-γ-linolenic acid (20:3n-6), and arachidonic acid (20:4n-6). The Δ-5 desaturase (D5D) activity was estimated as the 20:4/20:3 ratio. Associations with diabetes were estimated with Cox proportional hazards models. RESULTS: Higher concentrations of 18:2 were inversely associated with type 2 diabetes risk, particularly in lysophosphatidylcholines (hazard ratio [HR] per 1 SD 0.53; 95% CI 0.23-1.26) and monoacylglycerols (HR 0.59; 0.38-0.92). Higher concentrations of 20:3 in phospholipid classes phosphatidylcholines (HR 1.63; 1.23-2.14), phosphatidylethanolamines (HR 1.87; 1.32-2.65), and phosphatidylinositol (HR 1.40; 1.05-1.87); free fatty acids (HR 1.44; 1.10-1.90); and cholesteryl esters (HR 1.47; 1.09-1.98) were linked to higher type 2 diabetes incidence, and these associations remained statistically significant after correction for multiple testing. Higher 20:4 concentrations were not associated with risk. The estimated D5D activity in phospholipids and cholesteryl esters was associated with lower type 2 diabetes risk. Single nucleotide polymorphisms in the D5D-encoding FADS genes explained relatively high proportions of variation of estimated D5D activity in those lipid classes. CONCLUSIONS: Plasma n-6 PUFAs were associated differently with type 2 diabetes, depending on fatty acid and the lipid class.
引用
- Prada M, Eichelmann F, Wittenbecher C, et al. Plasma Lipidomic n-6 Polyunsaturated Fatty Acids and Type 2 Diabetes Risk in the EPIC-Potsdam Prospective Cohort Study. Diabetes Care. 2023. PMID: 36787959. doi:10.2337/dc22-1435
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。